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ABSTRACT 
The aim of present investigation was to formulate and characterize elastic liposomes as a delivery system for transdermal delivery 
of Verapamil hydrochloride, a drug having low oral bioavailability (approx 20%), short biological half-life and extensive first pass 
metabolism.Verapamil hydrochloride loaded elastic vesicles were prepared by a slightly modified extrusion method using soya 
phosphatidylcholine and span 80(edge activator). Prepared elastic vesicles were characterized for various parameters such as 
vesicle shape, vesicle size and size distribution, entrapment efficiency, elasticity measurements, stability studies and in vitro skin 
permeation studies through excised rat skin (Sprague Dawley) using a locally fabricated Franz diffusion cell. The entrapment 
efficiency of elastic vesicles was found to be 59.33.6%. In vitro skin permeation of verapamil hydrochloride through excised rat 
skin (Sprague Dawley) revealed that elastic vesicles led to an enhanced transdermal flux (50.24.52 g/cm2/h) of verapamil 
hydrochloride as compared to liposomes (11.62.12g/cm2/h). Decreased lag time (0.9 h) was also observed in case of elastic liposomes. Our 
results indicate the feasibility of elastic liposomes for transdermal delivery of verapamil hydrochloride for improved skin 
permeation. 
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INTRODUCTION 
Skin, the largest sense organ of the body serves as a 
barrier against physical, chemical and microbial attacks, 
acts as a thermostate in maintaining body temperature, 
plays a role in the regulation of blood pressure and 
protects against the penetration of ultraviolet rays. 
Natural function of the skin is the protection of the body 
against the loss of endogenous substances such as water 
and undesired influences. Skin, effectively the largest 
organ of the body, is a multipurpose, nonhomogeneous 
membrane with a complex structure. It contains and 
protects the internal body organs and fluids and 
exercises environmental control over the body 
regarding temperature and humidity. In addition, the 
skin is a communicating organ, relaying the sensations 
of heat, cold, touch, pressure, and pain to the central 
nervous system. Skin has been routinely used as the site 
for administration of dermatological drugs to achieve a 
localized pharmacological action in the skin. The skin can 
also serve as the port of administration for systemically 
active drugs. The drug applied topically will absorb first 
into the blood circulation and then be transported to target 
tissues to achieve its therapeutic concentration. The 
transdermal delivery of drugs through the skin to the 
systemic circulation provides a convenient route of 
administration for a variety of clinical indications.1 
Skin acts a major target as well as a principal barrier for 
topical/transdermal drug delivery and always remains an 
attraction of scientists for delivery of bioactives because of 
its impermeable nature. The skin is divided into 2 main 
structural layers: the epidermis and the dermis. The outer 
most layer of the epidermis, the stratum corneum provides 
a protective barrier that prevents the loss of 
physiologically essential substances and provides greatest 
resistance to penetration and is the rate limiting step of 
percutaneous absorption. The epidermis also has 
immunologic functions and provides some protection of 
the skin from ultraviolet light via the pigment system. Low 
permeability of drugs through stratum corneum, barrier 
layer of the skin limits the utility of topical drug delivery. 
The topical administration of drugs for the local treatment 
of skin diseases has been used for a long time, but the use 
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of transdermal delivery for the systemic action is relatively 
new and attention seeking. Various physical approaches as 
iontophoresis, microporation, electrophoresis, 
sonophoresis, pressure wave, magnetophoresis, chemical 
approaches as chemical penetration enhancers and 
prodrug approach have been employed to breach the skin 
barrier. Penetration enhancement with special formulation 
approache is mainly based on the usage of colloidal 
carriers. Submicron-sized particles are intended to 
transport entrapped active molecules into the skin. Various 
nanosized colloidal and vesicular carriers as liposomes, 
niosomes, nanoemulsions, ethosomes, elastic liposomes 
and solid lipid nanoparticles are gaining much more 
attention of scientists for topical delivery of therapeutics 
because they are able to cross the barrier nature of skin 
through different mechanisms.2-7  
Elastic liposomes are at the forefront of the rapidly 
developing field of nanotechnology with several potential 
applications in skin delivery. Elastic liposomes differ from 
commonly used liposomes in that they are much more 
flexible and adaptable. Elastic liposomes combine 
phosphatidylcholine with edge activators/surfactants to 
form flexible membranes. The crucial feature of elastic 
liposomes in comparision with standard liposomes and other 
types of lipid suspensions is the flexibility of vesicle membrane 
and stress dependent adaptability. These liposomes with 
their characteristic fluid membrane and high elasticity are 
able to penetrate the narrow pores much smaller than their 
own diameter. They can deform and pass through narrow 
constriction without measurable loss. This high 
deformability gives better penetration of intact vesicles.8-9 
Verapamil 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-
dimethoxyphenyl)ethyl](methyl)amino}-2-(1-methylethyl) 
pentanenitrile hydrochloride is a calcium channel blocking 
anti-anginal agent that regulates high blood pressure by 
decreasing myocardial contractility, heart rate and impulse 
conduction. It is used in treatment of hypertension, angina 
pectoris and supraventricular arrhythmias.  Topically and 
transdermally verapamil hydrochloride may be utilized in 
peyronie’s disease either alone or in combination with 
trifluoperazine and magnesium sulfate.10-11 Verapamil 
hydrochloride on oral administration undergoes extensive 
first pass metabolism which is responsible for its low 
bioavailability i.e. 20%. It has a short biological half life of 
just 4.8 hours, due to its short time of action it is required 
to administer many times a day decreasing patient 
compliance. Due to its short biological half life, high hepatic 
clearance and low bioavailability verapamil hydrochloride 
seems to be a suitable candidate for transdermal drug 
delivery. Hence noninvasive delivery via transdermal route 
utilizing vesicular approach i.e. elastic liposomes could be a 
better option for effective, sustained delivery of verapamil 
hydrochloride.  
Feasibility of transdermal delivery of verapamil 
hydrochloride was earlier demonstrated by researchers 
across excised rat skin and porcine ear skin. Gungor et al 
developed matrix-type transdermal patches of verapamil 
hydrochloride and investigated various terpenes as chemical 
enhancer to improve skin penetration. Microneedles and 
microneedle rollers mediated transdermal drug delivery of 
verapamil hydrochloride and amlodipine besylate showed 
enhanced transdermal flux from porcine ear skin.12-17   
The objective of present study was to deliver verapamil 
hydrochloride by transdermal route utilizing novel vesicular 
approach for enhanced skin permeation. Specially designed 
vesicles elastic liposomes have shown a great deal of success 
in transdermal panorama. Elastic liposomes are lipid vesicles 
consisting of phospholipids and an edge activator that 
destabilizes the lipid bilayer of the vesicles and increases 
the flexibility of the bilayer. Due to the flexible nature of 
membrane these vesicles are capable of squeezing 
themselves through the intracellular regions of the stratum 
corneum and penetrate into the deep skin strata. Prepared 
elastic svesicles were characterized for various parameters 
such as vesicle shape, vesicle size and size distribution, 
entrapment efficiency, elasticity measurements, stability 
studies and in vitro skin permeation studies through 
excised rat skin (Sprague Dawley). 
MATERIALS AND METHODS 
Materials 
Soya phosphatidylcholine (99%), Span 80, Sephadex G-50, 
Triton X-100 were purchased from Sigma (St. Louis, MO, 
USA). Verapamil hydrochloride was received as a gift 
sample from Samarth Life Sciences Pvt. Ltd. (Solan, India). 
All other chemicals and solvents were of analytical grade 
and freshly prepared distilled water was used wherever 
required. 
Preparation of vesicular systems 
The elastic liposomes were prepared by a slightly modified 
extrusion method reported by Maghraby et al., 2000.18 
Different batches of elastic liposomes were prepared using 
different proportions of surfactant, soya 
phosphatidylcholine and drug. The accurately weighed 
amounts of soya phosphatidylcholine and surfactant were 
taken and dissolved in ethanol in a clean, dry, round 
bottom flask. Ethanol was removed by rotary evaporation 
above the lipid transition temperature (Rotary Evaporater, 
Superfit, Ambala, India). Final traces of solvent were 
removed under vaccum overnight. The deposited lipid film 
was hydrated with varying concentrations of drug in PBS 
(pH 6.5) by rotation (60 rpm, 1 hr) at room temperature. 
The resulting vesicles were swollen for 2 hr at room 
temperature. These vesicles were extruded through a 
sandwich of 100 and 200 nm polycarbonate membranes 
(Milipore, USA). Compositions of different batches of elastic 
liposomes as shown in Table 1.Conventional liposomes 
were prepared using Cast film method. 
Table 1: Composition of different elastic liposomal 
formulations 
S. 
No. 
Formulation 
Code 
Soya PC 
(mg) 
Span 80 
(mg) 
1. ELS1 95 5 
2. ELS2 90 10 
3. ELS3 85 15 
4. ELS4 80 20 
5. ELS5 75 25 
 
Incorporation of verapamil hydrochloride in elastic 
liposomes 
 Verapamil hydrochloride was incorporated into vesicular 
formulations at saturating concentration. To determine the 
maximum amount of drug incorporated, increasing 
amounts of verapamil hydrochloride were added during 
preparation of elastic liposomes. Vesicular formulations 
were examined over a period of 14 days using Light 
Microscopy (Leica, DMLB, Switzerland).   
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Characterisation of elastic liposomes 
Entrapment efficiency 
Prepared elastic vesicles were separated from the 
unentrapped drug by Sephadex G-50 minicolumn 
centrifugation technique. The vesicles were lysed by Triton 
X-100 (0.5% w/w) and entrapped drug was estimated 
spectrophotometrically at 279 nm.19-20  
Vesicles size  
Elastic vesicles were visualized using a Philips 
transmission electron microscope (CM12 Electron 
Microscope, Eindhoven, Netherlands) with an accelerating 
voltage of 100 kV. A drop of the sample was placed on to a 
carbon-coated copper grid to leave a thin film. Before the 
film dried on the grid, it was negatively stained with 1% 
phosphotungastic acid (PTA). A drop of the staining 
solution was added on to the film and excess of the solution 
was drained off with a filter paper. The grid was allowed to 
thoroughly dry in air and samples were viewed in a 
transmission electron microscope.21  
Vesicle size distribution 
The size distribution of elastic vesicles was measured in 
two sets of triplicates in a multimodal mode, by Dynamic 
Light Scattering (DLS) technique using a computerized 
inspection system (Malvern Zetamaster, ZEM 5002, 
Malvern,UK). Vesicular suspension was appropriately 
diluted with PBS (pH 6.5) and the measurements were 
conducted in triplicate.22 
Turbidity measurements 
The turbidity of different elastic liposomes and 
conventional liposomes were determined using PBS (pH 
6.5) as blank (Nephalometer, Superfit, Mumbai, India). 
Elasticity of vesicle membrane 
The deformability study was conducted for the elastic 
liposomes against the standard liposome preparation. 
Briefly, the flux of vesicles suspension through a large 
number of pores of known size (through a sandwich of 
polycarbonate filters with pore diameter between 50 and 
200 nm, depending on the starting vesicle suspension), was 
driven by an external pressure of 2.5 bar.23 The amount of 
vesicle suspension, which was extruded during 5 min, was 
measured and vesicle size and size distribution were 
monitored by DLS measurement before and after filtration. 
The experiment was performed in triplicate and each 
sample was analyzed twice. The elasticity of vesicle 
membrane was calculated by using the following formula 24  
D = J   
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

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r  
Where, D, elasticity of vesicle membrane; J, amount of 
suspension, 
Which was extruded during 5 min; rv, size of vesicles (after 
passes); and rp, pore size of the barrier. 
Physical stability of elastic liposomes 
The drug retentive behavior of vesicles was determined by 
keeping elastic liposomes at four different temperature 
conditions, i.e. 4-8ºC (Refrigerator), 252ºC (Room 
temperature), 372ºC and 452ºC for a period of 5 weeks. 
The elastic liposomes were kept in sealed ampoules after 
flushing with nitrogen. Samples were withdrawn 
periodically and analyzed for the drug content. Stability of 
elastic liposomes was also assessed by the measuring size 
and structure using DLS and TEM.   
Skin permeation and deposition studies 
The in-vitro skin permeation of verapamil hydrochloride 
from elastic liposomes was studied using a locally 
fabricated Franz diffusion cell. The receptor compartment 
contained 10 ml PBS (pH 6.5) and was constantly stirred by 
magnetic stirrer (Expo India Ltd., Mumbai, India) at 100 
rpm. Sprague Dawley rat skin was mounted between the 
donor and receptor compartments. Experiments were carried 
out for 24h at 37±1ºC, with donor compartments each 
containing 1 ml of different compositions, (a) elastic 
liposomes, (b) liposomes, (c) plain drug solution. Samples 
were withdrawn through the sampling port of the diffusion 
cell at predetermined time intervals over 24 hr and analyzed. 
The receptor phase was immediately replenished with equal 
volume of fresh diffusion buffer. Sink conditions were 
maintained throughout the experiment. In-vitro drug release 
study from elastic liposomes was repeated with cellophane 
membrane using the same method as described above. 
The amount of verapamil hydrochloride remained in the 
skin was determined at the end of the in-vitro 
permeation experiment (24 hr). The skin was washed 10 
times using a cotton cloth immersed in methanol. A 
sample of skin was weighed and homogenized in 1ml of 
methanol for 5 min with an electric stirrer. The resulting 
solution was centrifuged for 10 min at 7000 rpm. The 
supernatant was analyzed for drug. The cumulative 
amount of drug permeated per unit area was plotted as a 
function of time, the steady state permeation rate (Jss) and 
lag time (TL, hr) were calculated from the slope and X-
intercept of the linear portion, respectively. 
RESULTS AND DISCUSSION 
Elastic liposomes combine phosphatidylcholine with edge 
activators/surfactants to form flexible membranes. These 
liposomes with their characteristic fluid membrane and 
high elasticity are able to penetrate the narrow pores much 
smaller than their own diameter. The slightly modified 
extrusion method reported by EI Maghraby et al., 2000 was 
used to prepare verapamil hydrochloride elastic liposomes. 
Span 80 was selected as edge activator because it is 
biocompatible and pharmaceutically acceptable. Various 
formulation variables which may affect the formulation i.e. 
lipid: surfactant ratio was studied in order to produce 
optimized drug loaded vesicles. Optimum ratio of soya 
phosphatidylcholine and surfactant was found to be 85:15 
w/w for the preparation of elastic liposomes. 
For optimization of drug amount, the elastic liposomes 
were prepared using varying concentrations of drug, 
followed by morphological characterization and 
determination of entrapment efficiency. The maximum 
concentration of verapamil hydrochloride that could be 
incorporated into elastic liposomes was found to be 15mg 
with percentage entrapment efficiency of 59.33.6%. On 
further increasing the amount of drug, precipitated drug 
crystals were observed, this precipitation of drug crystals 
may be due to the saturation of the vesicles. Further, a 
lower entrapment of verapamil hydrochloride in elastic 
liposomes may be due to the hydrophilic nature of the 
drug. 
 
 
 
Jain et al                                                                                                                    Journal of Drug Delivery & Therapeutics. 2018; 8(6):16-21  
ISSN: 2250-1177                                                                                  [19]                                                                                    CODEN (USA): JDDTAO 
Table 2: Drug loading in elastic liposomal formulations 
S. 
No. 
Amount of 
drug (mg) 
Microscopic 
observation 
Entrapment 
efficiency (%) 
1. 5 NO 51.12.6 
2. 10 NO 53.73.1 
3. 15 NO 59.33.6%. 
4. 20 O 57.41.8 
NO- Not observed, O- Observed 
Various parameters of elastic liposomes were evaluated 
like vesicles size, vesicle size distribution, turbidity 
measurements, entrapment efficiency, elasticity of vesicle 
membrane, physical stability, skin permeation and 
deposition studies. 
Entrapment efficiency of different elastic liposomal 
formulations was investigated by minicolumn 
centrifugation method. Formulation ELS3 showed 
maximum entrapment efficiency of 59.33.6% so it was 
selected for further evaluation parameters. The 
entrapment efficiency first increased up to 15% w/w 
concentration of surfactant, after which decrease in 
entrapment efficiency was observed. The entrapment 
efficiency is highest at 15% surfactant concentration. The 
influence of surfactant concentration on the entrapment 
efficiency has been shown in Table 3. 
Table 3: Entrapment efficiency of different elastic 
liposomes 
S. 
No. 
Formulation 
code 
Surfactant 
concentration 
(%w/w) 
Entrapment 
efficiency 
(%) 
1. ELS1 5 45.91.9% 
2. ELS2 10 53.22.7% 
3. ELS3 15 59.33.6% 
4. ELS4 20 51.43.2% 
5. ELS5 25 42.14.3% 
 
The size of vesicle was measured for formulations extruded 
through polycarbonate membrane and the results were 
expressed as the average vesicle size. Average vesicle size 
of elastic liposomes was found in between 100-150 
nm.Vesicle size of optimized ELS3 formulation was found to 
be 12610. As the surfactant concentration increases, the 
size of vesicles increases. Visualization by TEM revealed 
the unilamellar, spherical shape of elastic liposomes. 
Polydispersity index of these formulations were found in 
the range of <0.1(0.06) suggesting homogeneous nature of 
elastic liposomes. 
 
Figure 1 TEM (Transmission Electron Microscopy) 
Photograph of Elastic Liposome (X 80,000) 
Turbidity measurement of different elastic liposomes was 
done by using Nephalometer. Maximum turbidity was 
found in the formulations containing lipid surfactant 
concentration of 85:15 w/w suggesting fair population of 
vesicles. Low turbidity values of different elastic liposomes 
suggesting that vesicles might have ruptured or converted 
into mixed micells which have been reported less 
deformable in nature. These mixed micelles also have less 
skin permeability as compared to elastic liposomes. 
 
Table 4: Effect of phospholipid to surfactant ratio on turbidity of drug loaded elastic liposomes 
S. No. Formulation code Phospholipid to surfactant 
ratio (%w/w) 
Turbidity 
(N.T.U.) 
1. ELS1 95:5 16.94.1 
2. ELS2 90:10 19.33.5 
3. ELS3 85:15 26.25.2 
4. ELS4 80:20 20.84.6 
5. ELS5 75:25 15.46.3 
 
The crucial feature of elastic liposomes in comparison with 
standard liposomes and other types of the drug loaded lipid 
suspensions is the flexibility of vesicle membrane and stress 
dependent adaptability. ‘Elasticity’ is the measure of 
flexibility of the vesicles to penetrate the skin 
spontaneously and minimize the risk of complete vesicle 
rupture in the skin. This feature of elastic liposomes is 
chiefly due to the presence of surface active agent in 
appropriate proportion and in our case it was found to be 
65.45.5.  Elastic vesicles with this flexibility may 
proficiently approach the deep subcutaneous layers for 
effectual delivery of drug and thereof sustained action. 
Maximum elasticity was observed for formulation 
containing 15% w/w surfactant concentration. Further 
increase in surfactant concentration decreased elasticity 
may be due to the conversion of vesicles to mixed micelles. 
 
Table 5: Effect of surfactant concentration on elasticity of drug loaded elastic liposomes 
S. No. Formulation code Surfactant concentration (%w/w) Elasticity 
1. ELS1 5 29.63.4 
2. ELS2 10 36.81.9 
3. ELS3 15 65.45.5 
4. ELS4 20 39.74.3 
5. ELS5 25 31.42.8 
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Stability studies of verapamil hydrochloride formulations 
suggested that there was no significant difference in shape 
lamellarity and particle size of vesicles stored at 
refrigeration temperature and room temperature for five 
weeks suggesting their stability under given conditions. 
But, under condition of elevated temperature, a significant 
alteration in morphology, vesicle size as well as increased 
drug leakage was observed. This may be due to the effect of 
temperature on the gel to liquid transition of lipid bilayers. 
Hence loss of drug from vesicles was observed. 
Refrigerated conditions were found to be best for storage 
with negligible drug leakage at all times. 
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Figure 2: Effect on vesicle size of elastic liposomes 
after storage 
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Figure 3: Effect of temperature on drug leakage from 
elastic liposomes 
Skin permeation potential of verapamil hydrochloride 
loaded elastic liposomes was investigated by studying 
various parameters as transdermal flux across excised rat 
skin, lag time  and skin deposition of the drug. The 
cumulative amount of drug permeated per unit area was 
plotted as a function of time and steady state transdermal 
flux was observed. The steady state transdermal fluxes for 
different elastic liposomes were observed between 
15.14.2 g/h/cm2 and 50.24.52 g/h/cm2. Verapamil 
hydrochloride loaded elastic liposomes containing 15% 
w/w Span 80 revealed a transdermal flux of 50.24.52 
g/cm2/h and lag time of 0.9 h. Conventional liposomes and plain 
drug solution provided significantly lower flux values and longer lag 
time of 11.41.23 g/cm2/h, 2.3 h and 3.140.88 g/cm2/h, 2.9 
h; respectively as compared to elastic liposomes.  
Verapamil hydrochloride loaded elastic liposomes led to 
better percent skin drug deposition (5.610.4) as 
compared to conventional liposomes (1.782.5) and plain 
drug solution (1.191.6), thus providing sustained delivery 
of verapamil hydrochloride. Our results were analogous to 
that of available reports on transdermal delivery of 
verapamil hydrochloride, as reported earlier by Kaur et al., 
2014 (49.96g/cm2/h). Kaur et al investigated the effect of 
stainless steel solid microneedles and microneedles rollers 
on percutaneous permeation of verapamil hydrochloride 
and amlodipine besylate through porcine ear skin and 
suggested improved permeation of both the drugs.  
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Figure 4: % Cumulative Drug Release from elastic 
liposomes for 24 hours
 
Table 6: Composition and characterization of verapamil hydrochloride loaded elastic liposomes 
S.No.   Parameters                                                          Elastic liposomes                         Liposomes                              Plain drug solution        
                                                                                             PC:S (85:15w/w) 
 
1         Vesicular shape                                                   Spherical, unilamellar                Spherical, multiilamellar              −                   
2         Vesicular size (nm)                                            12610                                           4347.0                                              −                           
3         Polydispersity index                                          0.055                                               0.058                                                   −                           
4         % Entrapmemt efficiency                                59.33.6%                                      39.31.8                                            −                          
5         Deformability index                                           65.45.5                                         17.62.4                                             −                                   
6         Transdermal Flux  across rat skin (g/cm2/h)      50.24.52                                                11.41.23                                                         3.140.88 
7          Lag time (h)                                                         0.9                                                    2.3                                                       2.9 
8          Percent  skin drug deposition                                     5.610.4                                         1.782.5                                            1.191.6                            
Values represent mean±SD (n = 3). 
CONCLUSION 
In the present investigation skin permeation profile of 
verapamil hydrochloride through elastic liposomes was 
observed. Enhanced transdermal flux and decreased lag 
time of verapamil hydrochloride via elastic liposomes 
concluded that problems associated with verapamil 
hydrochloride i.e. low oral bioavailability, hepatic first pass 
metabolism and short biological half life could be sorted 
out via elastic liposomes. Enhanced delivery of bioactive 
molecules through the skin and cells by means of 
aforementioned carriers opens numerous challenges and 
opportunities for novel improved therapies. 
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